Late last month, Comcast (CMCSA) announced that it had introduced its Xfinity Prepaid Internet service.
On April 20, 2017, Comcast’s (CMCSA) stock was trading at $38.00, 2.7% above its 100-day and 20-day moving averages of $37 and exactly at its 50-day moving average of $38.
Comcast’s (CMCSA) X1 set-top box, which has been the key in differentiating the company from competitors, is driving its video business.
On April 20, 2017, Comcast’s (CMCSA) stock closed at $38.00. Comcast is expected to announce its fiscal 1Q17 results on April 27.
On April 20, 2017, Noble Energy’s short interest as a percentage of its float was ~4.7%. At the beginning of the year, its short interest ratio was ~3.3%.
Approximately 53% of the analysts rate Noble Energy (NBL) as a “buy” and 32.3% rate it as a “hold.” The average broker target price is $47.47.
Noble Energy (NBL) stock has mostly been on a downtrend since the beginning of 2017. Earlier in the year, the stock saw some upward momentum.
The midpoint of Noble Energy’s 2017 production growth guidance is 420 Mboepd. It represents 5% production growth compared to its levels in 2016.
Noble Energy is expected to report its 1Q17 earnings on May 1 after the markets close. The company’s consensus revenue estimates stand at $987 million.
As of April 21, 2017, there are five analysts tracking Novartis. Of those, two have recommended a “strong buy,” and one has recommended a “buy.”
Sandoz’s revenues are expected to rise in 1Q17 following an increased demand for biopharmaceuticals such as biosimilars and Glatopa.
Analysts expect Alcon’s 1Q17 revenues to fall due to lower equipment sales in the surgical franchise and lower sales in contact lens products.
Analysts expect Novartis’s (NVS) revenues to remain nearly flat at ~$11.7 billion in 1Q17 following the effects of its acquisitions and divestitures.
Novartis’s (NVS) Innovative Medicines segment includes products for therapeutic areas such as oncology, cardiometabolic, immunology, and dermatology.
Novartis is set to release its 1Q17 earnings on April 25, 2017. Analysts estimate its 1Q17 EPS at $1.12 with revenues of ~$11.7 billion.
As of April 19, 73.0% or 16 out of 22 analysts have a “buy” rating for PepsiCo’s (PEP) stock. Six analysts have a “hold” rating.
As of April 19, PepsiCo (PEP) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.1x.
PepsiCo (PEP) delivered revenue growth of 5.0% in 4Q16 after eight consecutive quarters of declines in its top line.
PepsiCo (PEP) is slated to announce its fiscal 1Q17 results on April 26. The company exceeded analysts’ earnings expectations in each of the four quarters in fiscal 2016.
Snack and beverage giant PepsiCo (PEP) is scheduled to announce its fiscal 1Q17 results on April 26. Here’s what you need to know.